Who Owns LINEAGE CELL THERAPEUTICS IN (LCTX)? -- Institutional Holders (2026-06-30)
161 institutions reported holding $154.3M of LINEAGE CELL THERAPEUTICS IN (LCTX) in SEC 13F filings for 2026-06-30. Largest institutional holders: BROADWOOD CAPITAL INC ($64.9M), BlackRock, Inc. ($17.3M), VANGUARD GROUP INC ($15.8M), Defender Capital, LLC. ($8.6M), GEODE CAPITAL MANAGEMENT, LLC ($6.9M). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|
| 1 | BROADWOOD CAPITAL INC | $64.9M | 49.6M | Hold |
| 2 | BlackRock, Inc. | $17.3M | 13.2M | Added |
| 3 | VANGUARD GROUP INC | $15.8M | 12.1M | Added |
| 4 | Defender Capital, LLC. | $8.6M | 6.6M | Trimmed |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | $6.9M | 5.3M | Added |
| 6 | RAFFLES ASSOCIATES LP | $6.8M | 5.2M | Trimmed |
| 7 | FIFTH THIRD BANCORP | $6.0M | 4.6M | Hold |
| 8 | MILLENNIUM MANAGEMENT LLC | $4.0M | 3.0M | Trimmed |
| 9 | STATE STREET CORP | $3.0M | 2.3M | Added |
| 10 | NORTHERN TRUST CORP | $2.2M | 1.7M | Added |
| 11 | MORGAN STANLEY | $1.9M | 1.5M | Trimmed |
| 12 | RENAISSANCE TECHNOLOGIES LLC | $1.8M | 1.3M | Trimmed |
| 13 | MARSHALL WACE, LLP | $1.7M | 1.3M | Trimmed |
| 14 | UBS Group AG | $900,036 | 687,051 | Trimmed |
| 15 | RED CRANE WEALTH MANAGEMENT, LLC | $782,415 | 597,263 | Hold |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $756,440 | 577,435 | Added |
| 17 | Sixth Street Partners Management Company, L.P. | $756,440 | 577,435 | New |
| 18 | BARCLAYS PLC | $666,354 | 508,668 | Added |
| 19 | VESTOR CAPITAL, LLC | $658,000 | 21,985 | New |
| 20 | CITADEL ADVISORS LLC | $609,896 | 465,569 | Added |
| 21 | Squarepoint Ops LLC | $582,654 | 444,774 | Added |
| 22 | GOLDMAN SACHS GROUP INC | $567,578 | 433,266 | Trimmed |
| 23 | BANK OF AMERICA CORP /DE/ | $555,928 | 424,373 | Added |
| 24 | Bank of New York Mellon Corp | $513,094 | 391,675 | Added |
| 25 | FLPUTNAM INVESTMENT MANAGEMENT CO | $398,976 | 304,562 | New |
Source: SEC Form 13F filings · as of 2026-06-30